RSCM
NGNE icon

Rock Springs Capital Management’s Neurogene NGNE Stock Holding History

Rock Springs Capital Management’s Portfolio NGNE Stock Details NGNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.1M Hold
104,339
– – 0.12% 88
2025
Q4 		$2.15M Hold
104,339
– – 0.11% 89
2025
Q3 		$1.81M Hold
104,339
– – 0.11% 78
2025
Q2 		$1.56M Hold
104,339
– – 0.1% 80
2025
Q1 		$1.22M Buy
104,339
+8,932
+9% +$155K 0.07% 85
2024
Q4 		$2.18M Buy
+95,407
New +$3.55M 0.08% 91

Other funds holding NGNE

SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.34B AUM 204.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
TECP
Trails Edge Capital Partners Atlanta, Georgia $425M AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $50.9B AUM 42.89% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $51.9B AUM 40.86% 1-Year Est. Return